Carolinas Inc - Local Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Cepheid, Inc. (NQ: CPHD)
33.13 USD  -0.37 (-1.10%)
Official Closing Price  /  Updated: 4:00 PM EDT, Jun 18, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about Cepheid, Inc.
 
< Previous 1 2 3 4 5 6 7 Next >
Cepheid Welcomes Executive Vice President of Global Operations
May 07, 2013
from PR Newswire
Cepheid to Webcast Upcoming Financial Presentations
May 01, 2013
from PR Newswire
Free Research Reports on CBST, COF, CPHD and ETFC Issued by the Bedford Report
April 22, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit Read More
from Marketwired News Releases
Cepheid Reports 2013 First Quarter Results
April 18, 2013
Clinical Reagent Revenue Growth of 23% Driven by Continued Momentum of Xpert® Test Portfolio Read More
from PR Newswire
Cepheid Schedules 2013 First Quarter Results Announcement And Webcast
April 04, 2013
from PR Newswire
Scientific Profits: Equipment & Innovation Driving Tomorrow - Research Report on Sensata Technologies Holding, Garmin, Cepheid, Analogic and FEI
March 14, 2013
from PR Newswire
Testing Positive for Stability & Growth - Research Report on CombiMatrix Corporation, Cepheid, PerkinElmer, Inc., Life Technologies Corp. and Laboratory Corp. of America Holdings
February 25, 2013
from PR Newswire
Cepheid And Oregon Health & Science University Collaborate To Develop Oncology Assays For GeneXpert® System
February 19, 2013
from PR Newswire
Cepheid Announces Board of Directors Changes
February 14, 2013
from PR Newswire
Cepheid to Webcast Upcoming Financial Presentations
January 31, 2013
from PR Newswire
Cepheid Reports Fourth Quarter And Full Year 2012 Results
January 24, 2013
Clinical Reagents Grow 32% in 2012 Read More
from PR Newswire
Cepheid Announces Chlamydia and N. gonorrhoeae Test Categorized 'Moderate Complexity' by FDA
January 15, 2013
Xpert CT/NG Makes Same-Day Consultation and Treatment Possible for Two Most Common STDs Read More
from PR Newswire
Cepheid Announces Update On Xpert® Test Availability
January 08, 2013
Preliminary Q4 2012 Revenue of Approximately $92 Million Reflects Stronger Than Expected Commercial Clinical Performance Offset By Lower HBDC Read More
from PR Newswire
Cepheid Receives FDA Clearance for Xpert CT/NG, Delivering Rapid Detection and Differentiation of Chlamydia and N. gonorrhoeae
December 27, 2012
Rapid, On-Demand Results Deliver New Confidence in Same-Day Patient Consultation and Treatment Read More
from PR Newswire
Cepheid to Webcast Upcoming Financial Presentations
November 28, 2012
from PR Newswire
Cepheid Announces Executive Vice President Emerging Markets
November 05, 2012
from PR Newswire
Cepheid to Webcast Upcoming Financial Presentations
October 25, 2012
from PR Newswire
Cepheid Reports 2012 Third Quarter Results
October 18, 2012
from PR Newswire
Cepheid Announces Preliminary 2012 Third Quarter Revenue Results
September 26, 2012
Xpert® Cartridge Backorders to Ship in October, Full Year Revenue Guidance Unchanged Read More
from PR Newswire
Abaxis Announces Settlement of Patent Litigation With Cepheid
September 26, 2012
from PR Newswire
Cepheid to Webcast Upcoming Financial Presentations
August 09, 2012
from PR Newswire
Cepheid Announces First Phase Of Xpert MTB/RIF Buy-Down For High Burden Developing Countries
August 06, 2012
from PR Newswire
Cepheid Announces Release of Updated Xpert BCR-ABL Monitor Test
July 25, 2012
CE-IVD Test Now Incorporates Lot-Specific Standardization Using WHO Standards Read More
from PR Newswire
Most Attractive Stocks: Baker Hughes, Wells Fargo, Micron, Cepheid, Merck, and Altria Group
July 23, 2012
from PR Newswire
Cepheid Reports 2012 Second Quarter Results
July 19, 2012
from PR Newswire
Cepheid Schedules 2012 Second Quarter Financial Results Announcement And Webcast
July 09, 2012
from PR Newswire
Cepheid Welcomes UNITAID Commitment To Broaden Access To "Ground-Breaking" Xpert® MTB/RIF
June 14, 2012
from PR Newswire
Cepheid to Webcast Upcoming Financial Presentations
May 31, 2012
from PR Newswire
Cepheid Receives FDA Clearance for GeneXpert Infinity-80 System for Initial Use with Xpert Flu Assay
May 24, 2012
Industry's Highest Throughput System Capable of More Than 2,000 Daily Test Results Read More
from PR Newswire
Cepheid Announces European Release of Xpert CT/NG and Xpert CT, Delivering Rapid Detection and Differentiation of Chlamydia and Gonorrhoeae
May 23, 2012
90-Minute On-Demand Results Deliver New Confidence in Same-Day Patient Consultation and Treatment Read More
from PR Newswire
< Previous 1 2 3 4 5 6 7 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here